Farm Animal Drugs Global Market Report 2024

The farm animal drugs market size has grown strongly in recent years. It will grow from $18.21 billion in 2023 to $19.58 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth observed in the historical period can be ascribed to the growing consumer demand for animal products, an increase in zoonotic diseases, emphasis on disease prevention and control, the intensification of livestock farming, and the global growth of the population.

The farm animal drugs market size is expected to see strong growth in the next few years. It will grow to $25.24 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be associated with the increasing awareness of antimicrobial resistance, the impact of climate change on livestock health, a growing emphasis on animal nutrition, the rise of alternative proteins, the utilization of phytogenic feed additives, the development of biopharmaceuticals for livestock, and the adoption of digital platforms for farm animal health management. Major trends expected in the forecast period encompass technological advancements in veterinary medicine, progress in precision livestock farming technologies, the implementation of blockchain technology for supply chain transparency, and the integration of AI and ML.

The anticipated growth in the farm animal drug market is expected to be propelled by the increasing consumption of meat. Meat consumption, which involves consuming animal flesh as a food source, is commonly derived from livestock such as chickens, pigs, or cattle. Farm animal drugs play a role in accelerating animal development and enhancing the transformation of food into meat. Therefore, the rising trend in meat consumption is likely to contribute to the increased demand for farm animal drugs. For example, in April 2023, as reported by the United States Department of Agriculture (USDA), beef meat consumption rose from 12,712 metric tons in 2021 to 12,803 metric tons in 2022. Pork meat consumption also increased from 9,918 metric tons in 2021 to 9,959 metric tons in 2022, while chicken meat consumption saw an increase from 17,164 metric tons in 2021 to 17,674 metric tons in 2022. Consequently, the surge in meat consumption is a driving factor for the farm animal drug market.

The rise in zoonotic diseases is expected to drive the growth of the farm animal drugs market. Zoonotic diseases are infectious diseases caused by pathogens that can be transmitted between animals and humans. Farm animal drugs play a crucial role in managing zoonotic diseases by preventing and treating infections that can be transmitted between animals and humans. For instance, a report published by Wiley in December 2022 highlighted an increase in the cases notification rate of various zoonotic diseases in the European Union in 2021 compared to 2020. These diseases include STEC infections (+36.9%), tularemia (+33.3%), salmonellosis (+14.3%), listeriosis (+14.0%), brucellosis (+12.3%), yersiniosis (+11.8%), and campylobacteriosis (+2.1%). Hence, the upsurge in zoonotic diseases is a key driver for the farm animal drugs market.


Leading firms in the farm animal drugs sector are concentrating on the development of antimicrobial drugs, specifically water-soluble granules, aimed at enhancing their competitive position. Water-soluble granules, characterized as solid, easily dissolvable particles in water, find utility in the precise dispersion of substances across various applications. For instance, in October 2023, Pharmgate Animal Health, a US-based livestock pharmaceutical company, secured FDA approval for Aivlosin Water Soluble Granules (WSG), containing 62.5% w/w tylvalosin as tylvalosin tartrate for female swine designated for breeding. This approval permits its use in replacement gilts, gestating sows, lactating sows, and weaned sows. Aivlosin, an antimicrobial drug, is prescribed by licensed veterinarians and is continuously administered at 50 ppm tylvalosin in drinking water for five consecutive days. The approval extends its application to controlling porcine proliferative enteropathy and swine respiratory disease in breeding females during outbreaks.

Prominent entities in the farm animal drugs market are actively engaged in devising inventive solutions, such as moxidectin injectable solutions, designed for effective cattle parasite control with the aim of maximizing market profitability. Moxidectin injectable solution, an antiparasitic drug in liquid form, is employed for treating and managing internal and external parasites in cattle. For example, in March 2023, Norbrook Laboratories Ltd., a UK-based pharmaceutical company, obtained FDA approval for Tauramox, the inaugural generic moxidectin injectable solution intended for the treatment and control of internal and external parasites in beef and nonlactating dairy cattle. Tauramox matches the concentration of moxidectin and is available over the counter in 10 mg/ml concentration, packaged in 250-ml and 500-mL bottles, with a recommended administration rate of 1 mL per 110 lb body weight.

In March 2022, SeQuent Scientific Limited, an India-based manufacturer specializing in active pharmaceutical ingredients, animal health products, and specialty chemicals, completed the acquisition of Nourrie Saúde e Nutrição Animal Ltda. for $5 million through its wholly-owned subsidiary, Alivira Animal Health Limited. This acquisition facilitated Alivira Animal Health Limited's expansion in Brazil by incorporating nutraceutical therapeutic products and Transuin, a ractopamine-based swine product currently manufactured by Nourrie. Nourrie Saúde e Nutrição Animal Ltda., based in Brazil, is dedicated to developing therapeutics and supplements for animal health.

Major companies operating in the farm animal drugs market report are Eli Lilly and Company, Boehringer Ingelheim GmbH, Zoetis Inc., Alembic Pharmaceuticals Limited, Elanco Animal Health Incorporated, Hester Biosciences Limited, Ceva Santé Animale SA, Virbac SA, Huvepharma Inc., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Laboratorios Hipra S.A., Norbrook Laboratories Ltd., Neogen Corporation, Ouro Fino Saude Animal Participacoes SA, Eco Animal Health Ltd., Biogenesis Bago SA, Laboratorios Calier S.A., Laboratorios Syva S.A., Jurox Pty Ltd., Kepro B.V., Kyoritsu Seiyaku Corp., Merck Animal Health, Vetoquinol SA, Intas Pharmaceuticals Ltd., Nippon Zenyaku Kogyo Co. Ltd., SeQuent Scientific Limited, Agrovet Market Animal Health, Orion Pharma Animal Health, Zydus Animal Health and Investments Limited.

Asia-Pacific was the largest region in the farm animal drugs market in 2023. The regions covered in the farm animal drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the farm animal drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of farm animal drugs include anti-infective, parasiticides, anti-inflammatory agents, anesthetics, analgesics, hormones, and related products, among others. Anti-infective drugs are specifically designed to combat infections, either by preventing the spread of infectious agents or by eradicating the pathogen causing the infection. These medications are valuable in treating severe infections in various animals, including equine and small animals. Administration routes for farm animal drugs include oral, parenteral, topical, and other methods. These drugs are distributed through channels such as veterinary hospitals, veterinary clinics, pharmacies, drug stores, and other outlets, catering to diverse animals, including livestock and equine species.

The farm animal drugs research report is one of a series of new reports that provides farm animal drugs market statistics, including the farm animal drugs industry's global market size, regional shares, competitors with farm animal drugs market share, detailed farm animal drugs market segments, market trends and opportunities, and any further data you may need to thrive in the farm animal drugs industry. This farm animal drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The farm animal drugs market consists of sales of endo-parasiticides, ectoparasitic ides, and endectocides. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.